ArticleFrontiers in pharmacology2020

Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway.

Rui Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.